Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report.

"Author Disclosures: G.-S.C. served on advisory board for Fred Hutch Protocol; served as board member for The Firland Foundation; served as consultant for Janssen; received research from NIH; received travel support from Joan Clark Funds for Fred Hutch Pulmonary Faculty. A.B. served as consultant for Zambon; served as speaker for Pfizer and Shire; received research support from Johnson & Johnson, SOS Oxygen, and Zambon. M.B. served as consultant for Allovir, EvrysBio, GlaxoSmithKline, Helocyte, Janssen, Kyorin, Merck, ReViral, Symbio, and Vir Bio; financial stake in Helocyte and Evrys Bio; received research support from Ansun Biopharma, Astellas, Gilead Sciences, GlaxoSmithKline, Janssen, Merck, Regeneron, Ridgeback, and Vir Bio; received royalties from UptoDate. J.W.C. is employed by Gilead Sciences and Johnson & Johnson; has financial stake in Johnson & Johnson. K. Cohen is employed by Johnson and Johnson; served on advisory committee for Paratek; served as consultant for AN2, HillRom, Insmed, Merck, Microbion, and Paratek; received research support from Burroughs Welcome Fund, COPD Foundation, Cystic Fibrosis Foundation, HillRom, Insmed, NIH/NHLBI, and Spero Therapeutics. N.D. served as consultant for Biofire and Merck; served on data safety and monitoring board for Clinipace and Contrafect. A.L.G. served as expert witness for Olympus; financial stake (partner) in LabCorp; received research support from Abbott, Bill & Melinda Gates Foundation, Cepheid, Gilead, Hologic, Janssen, Merck, Novavax, and Pfizer. M.M. served on advisory committee for Insmed, International Biophysics, and Savara; served as consultant for Shionogi and Zambon; served as speaker for Prime Education; received research support from Insmed. J.R. received research support from Pfizer. A.S. served as consultant for Enanta Pharmaceuticals and PsiOxus Therapeutics; received honoraria from Med Learning Group; received research support from NIH and Gateway for Cancer Research. B.S. received research support from the National Institute of Alcohol Abuse and Alcoholism, 1K08AA024512-01A1. K.L.W. served as consultant for Bristol Myers Squibb, Insmed, Lilly, Pfizer, and UCB; served on data safety and monitoring board for Abbvie and Roche; received research support for Bristol Myers Squibb. R.G.W. served on advisory committee for bioMerieux and Merck; served as consultant for La Jolla and Shionogi; served on data safety and monitoring board for Pfizer and Vir; served as speaker for bioMerieux and WebMD. S.E.E. has financial stake in and receives royalties from Pulmotect, Inc; holds US and international patents related to stimulating lung defenses. K. Crothers, S.A., C.C., C.S.D.C., R.P.D., C.A.H., T.M.H., S.M.H., B.J., J.K., R.M., A.P., M.I.R., J.T. reported no commercial or relevant non-commercial interests from ineligible companies."

"AcknowledgmentThe authors would like to thank Larry Mose and Marty Levkova for their assistance with the graphic design of the figures and Darrah Thomas for assistance in preparing the manuscript. The authors would also like to thank Kimberly Lawrence of the ATS for her guidance in managing the online workshop during the COVID-19 pandemic.This official workshop report was developed by an ad hoc subcommittee of the ATS Assembly on Pulmonary Infections and Tuberculosis.Members of the subcommittee are as follows:Guang-Shing Cheng, M.D. (Co-Chair)1,2Kristina Crothers, M.D. (Co-Chair)2,3Scott E. Evans, M.D. (Co-Chair)4Stefano Aliberti, M.D.5*Anne Bergeron, M.D., Ph.D.6*Michael Boeckh, M.D., Ph.D.1,2*Jason W. Chien, M.D., M.S.7*Catia Cilloniz, M.D.8,9*Keira Cohen, M.D.10*Nathan Dean, M.D.11,12*Charles S. Dela Cruz, M.D., Ph.D.13,14*Robert P. Dickson, M.D.15‡Alexander L. Greninger, M.D., Ph.D., M.S., M.Phil.16‡Chadi A. Hage, M.D.17‡Tobias M. Hohl, M.D., Ph.D.18*Steven M. Holland, M.D.19*Barbara E. Jones, M.D.12,20*Joseph Keane, M.D.21‡Mark Metersky, M.D.22‡Rachel Miller, M.D.23*Anne Puel, Ph.D.24,25,26‡Julio Ramirez, M.D.27*Marcos I. Restrepo, M.D.28,29*Ajay Sheshadri, M.D., M.S.C.I.4*Bashar Staitieh, M.D.30‡Jeffrey Tarrand, M.D.31‡Kevin L. Winthrop, M.D.32*Richard G. Wunderink, M.D.33*1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; 2Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington; 3Veterans Administration Puget Sound Health Care System, Seattle, Washington; 4Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas; 5University of Milan, Milan, Italy; 6Pneumology Department, University of Geneva, Geneva, Switzerland; 7Janssen Pharmaceuticals, Brisbane, California; 8University of Barcelona, Barcelona, Spain; 9Faculty of Health Sciences, Continental University, Huancayo, Peru; 10Johns Hopkins University, Baltimore, Maryland; 11Intermountain Medical Center, Murray, Utah; 12Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, Utah; 13Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University, New Haven, Connecticut; 14Veterans Affairs Connecticut Healthcare System, New Haven, Connecticut; 15University of Michigan Medical School, Ann Arbor, Michigan; 16Division of Virology, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington; 17Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Lung Transplant-UPMC, Pittsburgh, Pennsylvania; 18Department of Medicine, Human Oncology and Pathogenesis Program, and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York; 19National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; 20Veterans Administration, Salt Lake City, Utah; 21Clinical Medicine, St. James’s Hospital, Trinity College, Dublin, Ireland; 22University of Connecticut School of Medicine, Farmington, Connecticut; 23Division of Infectious Diseases, Department of Internal Medicine, Duke University, Durham, North Carolina; 24Laboratory of Human Genetics of Infectious Diseases Paris, INSERM, Paris, France; 25University of Paris Cité, Imagine Institute, Paris, France; 26Rockefeller University, New York, New York; 27Division of Infectious Diseases, University of Louisville, Louisville, Kentucky; 28South Texas Veterans Health Care System, San Antonio, Texas; 29Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Texas Health San Antonio, San Antonio, Texas; 30Division of Pulmonary, Allergy, Critical Care & Sleep Medicine, Department of Medicine, Emory University, Atlanta, Georgia; 31Department of Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas; 32Oregon Health Sciences University, Portland, Oregon; and 33Pulmonary and Critical Care Division, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.*Participant.‡Speaker."